MedComm
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Biochemistry (medical)
Q1
└
Cell Biology
Q1
└
Drug Discovery
Q1
Publisher
SJR 2025
2.930
Q1
SJR Score
H-Index
57
Citations / Doc (2yr)
11.73
Total Docs. (latest)
497
Total Citations (3yr)
7,971
Publication type
Journals
ISSN
26882663
Coverage
2020-2026
Journal Rank
#743
Subject Categories
Biochemistry (medical)
Q1
Cell Biology
Q1
Drug Discovery
Q1
Genetics
Q1
Genetics (clinical)
Q1
Immunology and Allergy
Q1
Oncology
Q1
Subject Areas
Aims & Scope
MedComm is interested in topics including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology and artificial intelligence.
The journal focuses on clinical and experimental advances on disease characteristics, pathogenic mechanism and medical techniques.
Topics of interest include, but are not limited to:
• Epigenetics, genomics, proteomics and metabonomics
• Non-coding RNA in disease
• Cell senescence and cell death
• Cellular signal transduction
• Gene therapy and gene editing
• Cancer immunology and immunotherapy
• Structural biology, chemical genomics and drug discovery
• High-definition imaging
• Artificial intelligence in medicine
• Stem cells and regenerative medicine
• Nanomedicine and drug delivery system
• Early disease diagnosis and biomarkers
• Clinical trials evaluating new treatments for cancer or other diseases
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Detailed Metrics
| Total Docs. (latest) | 497 |
| Total Docs. (3 years) | 666 |
| Total Refs. | 72,847 |
| Total Citations (3 years) | 7,971 |
| Citable Docs. (3 years) | 608 |
| Citations / Doc. (2 years) | 11.73 |
| Ref. / Doc. | 146.57 |
| % Female | 42.8% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of MedComm?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, MedComm has an SJR of 2.930 and is ranked Q1.
What is the SJR and quartile of MedComm?
MedComm has an SJR (SCImago Journal Rank) of 2.930 and its best quartile is Q1.
What is the H-index of MedComm?
The H-index of MedComm is 57, meaning 57 of its articles have each been cited at least 57 times.
Is MedComm indexed in Scopus?
Yes. MedComm is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.